RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $168,468,000 | -43.1% | 30,575 | 0.0% | 0.00% | – |
| Q4 2021 | $295,966,000 | -48.7% | 30,575 | -5.3% | 0.00% | – |
| Q3 2021 | $577,488,000 | -41.7% | 32,298 | -20.4% | 0.00% | – |
| Q2 2021 | $990,533,000 | +50.1% | 40,579 | +63.0% | 0.00% | – |
| Q1 2021 | $659,850,000 | +624.5% | 24,900 | +107.5% | 0.00% | – |
| Q4 2020 | $91,080,000 | +51.5% | 12,000 | 0.0% | 0.00% | – |
| Q3 2020 | $60,120,000 | -52.8% | 12,000 | -43.7% | 0.00% | – |
| Q2 2020 | $127,362,000 | +177.9% | 21,298 | +106.8% | 0.00% | – |
| Q1 2020 | $45,835,000 | -53.2% | 10,300 | 0.0% | 0.00% | – |
| Q4 2019 | $97,850,000 | +21.0% | 10,300 | 0.0% | 0.00% | – |
| Q3 2019 | $80,855,000 | -50.1% | 10,300 | 0.0% | 0.00% | – |
| Q2 2019 | $162,019,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |